查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1604673

基因組學市場中的人工智慧：按產品、功能、應用和最終用戶分類 - 2025-2030 年全球預測

Artificial Intelligence in Genomics Market by Offering (Services, Software), Function (Clinical Workflows, Gene Editing, Genome Sequencing), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，基因組學領域的人工智慧市場價值為5.6007億美元，預計到2024年將達到7.4023億美元，複合年成長率為32.65%，預計到2030年將達到40.483億美元。

基因組學領域的人工智慧 (AI) 產業利用 AI 技術分析遺傳資料並增強基因組研究，為個人化醫療、藥物發現和疾病預測提供寶貴的見解。基因組學中人工智慧的範圍擴展到資料驅動的醫療保健解決方案、改進的基因組診斷和突破性的基因研究，這對醫學進步至關重要。產生的大量基因組資料需要複雜的計算模型來解釋，這加劇了這種需求。人工智慧簡化了複雜的資料處理，並提供更快的分析和更準確的結果。其用途廣泛，包括管理基因組序列資料、利用人工智慧診斷遺傳疾病以及製定個人化治療計劃。最終用途多種多樣，包括醫療保健提供者、製藥公司、研究實驗室和學術機構。市場成長受到精準醫療需求不斷成長、人工智慧技術進步以及對基因組研究日益成長的興趣的影響。最新的商機在於人工智慧與次世代定序技術的融合，以及人工智慧主導的基因編輯工具的潛力。為公司提供的策略建議包括投資人工智慧平台開發以及與生物醫學研究人員和技術專家的合作夥伴關係以推動創新。然而，這個市場面臨著重大挑戰，包括資料隱私問題、監管障礙、高昂的實施成本以及對人工智慧模型及其結果進行可靠檢驗的需要。克服這些限制需要專注於開發透明的人工智慧系統並遵守道德標準。創新和研究的完美領域包括探索人工智慧在揭示複雜的遺傳交互作用中的作用以及開發預測基因組學工具。隨著情勢的迅速發展，相關人員必須保持敏捷，以應對法規環境並最大限度地發揮人工智慧在基因組學領域的潛力。由於其動態性，這個市場對於為新技術進步做出貢獻的公司來說具有巨大的潛力。

主要市場統計
基準年[2023] 56007萬美元
預測年份 [2024] 74023萬美元
預測年份 [2030] 40.483 億美元
複合年成長率（%） 32.65%

市場動態：基因組學市場快速發展的人工智慧的關鍵市場洞察

供需的動態交互作用正在改變基因組學領域的人工智慧市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 藥物發現和藥物開發產生的潛在需求
    • 製藥和生物技術產業擴大採用自動化系統
    • 透過基因組解決方案持續投資新藥發現
  • 市場限制因素
    • 人工智慧開發和實施的高成本
  • 市場機會
    • 提高人工智慧在臨床試驗資料管理中的適應性和高品質資料生成
    • 政府加大力度將人工智慧引入基因組學領域
  • 市場挑戰
    • 缺乏與基因組學人工智慧相關的熟練專家和資料安全挑戰

波特的五力：駕馭基因體學人工智慧市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對基因組市場人工智慧的影響

外部宏觀環境因素在塑造基因組學市場人工智慧的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解基因組學人工智慧市場的競爭格局

對基因組學市場中人工智慧的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣基因組學人工智慧市場廠商績效評估

FPNV 定位矩陣是評估基因組學市場人工智慧供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

在策略分析和推薦基因組學方面繪製人工智慧市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，基因組市場人工智慧的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 藥物發現和開發的潛在需求
      • 製藥和生物技術產業擴大採用自動化系統
      • 透過基因組解決方案持續投資新藥發現
    • 抑制因素
      • 開發和部署人工智慧的高成本
    • 機會
      • 提高人工智慧在臨床試驗資料管理和高品質資料生成方面的適應性
      • 政府在基因組學領域引入人工智慧的努力活性化
    • 任務
      • 缺乏與基因組學人工智慧相關的熟練專業人員和資料安全挑戰
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 基因組學中的人工智慧市場：透過提供

  • 服務
  • 軟體

第7章 基因組學中的人工智慧市場：按功能

  • 臨床工作流程
  • 基因編輯
  • 基因組序列分析
  • 預測基因檢測與預防醫學

第8章基因組學中的人工智慧市場：按應用分類

  • 農業和動物研究
  • 診斷
  • 藥物發現與開發
  • 精準醫療

第9章 基因組學中的人工智慧市場：按最終用戶分類

  • 政府機構
  • 醫療服務提供方
  • 製藥和生物技術公司
  • 研究中心和學術機構

第10章 美洲基因體學人工智慧市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區基因體學人工智慧市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章：歐洲、中東和非洲基因組學人工智慧市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • BenevolentAI Ltd.
  • Data4Cure Inc.
  • Deep Genomics Inc.
  • DNAnexus Inc.
  • Engine Biosciences Pte. Ltd.
  • Exscientia
  • Fabric Genomics Inc.
  • FDNA Inc.
  • Freenome Holdings, Inc.
  • Genomics AI
  • Genoox Ltd.
  • Illumina, Inc.
  • insitro
  • International Business Machines Corporation
  • Invitae Corporation
  • LGC Biosearch Technologies
  • Lifebit Biotech Ltd
  • Microsoft Corporation
  • MolecularMatch, Inc.
  • NVIDIA Corporation
  • Ocean Genomics
  • Owkin, Inc
  • PrecisionLife Ltd.
  • Sophia Genetics SA
  • Verge Genomics
Product Code: MRR-501246436E27

The Artificial Intelligence in Genomics Market was valued at USD 560.07 million in 2023, expected to reach USD 740.23 million in 2024, and is projected to grow at a CAGR of 32.65%, to USD 4,048.30 million by 2030.

The artificial intelligence (AI) in genomics industry involves leveraging AI technologies to analyze genetic data and enhance genomic research, offering invaluable insights into personalized medicine, drug discovery, and disease prediction. The scope of AI in genomics extends across data-driven healthcare solutions, improved genomic diagnostics, and groundbreaking genetic research, crucial for advancing medical science. Its necessity is underscored by the vast amount of genomic data generated that requires sophisticated computational models for interpretation. AI simplifies complex data processing, providing accelerated analysis and more precise outcomes. The applications span the management of genomic sequencing data, AI-powered diagnostics for genetic disorders, and the development of personalized treatment plans. End-use scope is vast, targeting healthcare providers, pharmaceutical companies, research laboratories, and academic institutions. Market growth is being influenced by increasing demand for precision medicine, advancements in AI technologies, and a rising interest in genomic research. The latest opportunities lie in the integration of AI with next-generation sequencing technologies and the potential for AI-driven gene editing tools. For businesses, strategic recommendations include investing in AI platform development and collaborative partnerships with biomedical researchers and technology experts to drive innovation. However, the market faces significant challenges, including data privacy concerns, regulatory hurdles, high costs of implementation, and a need for robust validation of AI models and their outcomes. Overcoming these limitations requires a focus on developing transparent AI systems and adhering to ethical standards. The best areas for innovation and research include exploring AI's role in dissecting complex genetic interactions and developing tools for predictive genomics. As the landscape rapidly evolves, stakeholders must remain agile to navigate regulatory environments and harness AI's full potential in genomics. With its dynamic nature, the market presents substantial possibilities for businesses poised to contribute to its emerging technological advancements.

KEY MARKET STATISTICS
Base Year [2023] USD 560.07 million
Estimated Year [2024] USD 740.23 million
Forecast Year [2030] USD 4,048.30 million
CAGR (%) 32.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Intelligence in Genomics Market

The Artificial Intelligence in Genomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Potential demand attributed to drug discovery and drug developments
    • Increasing adoption of automated systems in pharmaceuticals and biotechnology industries
    • Ongoing investments in novel drug discoveries with genomic solutions
  • Market Restraints
    • High costs associated with development and deployment of AI
  • Market Opportunities
    • Growing adaptability of AI for clinical trials data management along with high-quality data generation
    • Upsurging governmental initiatives for AI deployment in genomics
  • Market Challenges
    • Scarcity of skilled professionals and data security challenges associated with AI in genomics

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Intelligence in Genomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Intelligence in Genomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Intelligence in Genomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Intelligence in Genomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Intelligence in Genomics Market

A detailed market share analysis in the Artificial Intelligence in Genomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Intelligence in Genomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Intelligence in Genomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Intelligence in Genomics Market

A strategic analysis of the Artificial Intelligence in Genomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Intelligence in Genomics Market, highlighting leading vendors and their innovative profiles. These include BenevolentAI Ltd., Data4Cure Inc., Deep Genomics Inc., DNAnexus Inc., Engine Biosciences Pte. Ltd., Exscientia, Fabric Genomics Inc., FDNA Inc., Freenome Holdings, Inc., Genomics AI, Genoox Ltd., Illumina, Inc., insitro, International Business Machines Corporation, Invitae Corporation, LGC Biosearch Technologies, Lifebit Biotech Ltd, Microsoft Corporation, MolecularMatch, Inc., NVIDIA Corporation, Ocean Genomics, Owkin, Inc, PrecisionLife Ltd., Sophia Genetics SA, and Verge Genomics.

Market Segmentation & Coverage

This research report categorizes the Artificial Intelligence in Genomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Services and Software.
  • Based on Function, market is studied across Clinical Workflows, Gene Editing, Genome Sequencing, and Predictive Genetic Testing & Preventive Medicine.
  • Based on Application, market is studied across Agriculture & Animal Research, Diagnostics, Drug Discovery & Development, and Precision Medicine.
  • Based on End-User, market is studied across Government Organizations, Healthcare Providers, Pharmaceutical & Biotech Companies, and Research Centers & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Potential demand attributed to drug discovery and drug developments
      • 5.1.1.2. Increasing adoption of automated systems in pharmaceuticals and biotechnology industries
      • 5.1.1.3. Ongoing investments in novel drug discoveries with genomic solutions
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with development and deployment of AI
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing adaptability of AI for clinical trials data management along with high-quality data generation
      • 5.1.3.2. Upsurging governmental initiatives for AI deployment in genomics
    • 5.1.4. Challenges
      • 5.1.4.1. Scarcity of skilled professionals and data security challenges associated with AI in genomics
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Intelligence in Genomics Market, by Offering

  • 6.1. Introduction
  • 6.2. Services
  • 6.3. Software

7. Artificial Intelligence in Genomics Market, by Function

  • 7.1. Introduction
  • 7.2. Clinical Workflows
  • 7.3. Gene Editing
  • 7.4. Genome Sequencing
  • 7.5. Predictive Genetic Testing & Preventive Medicine

8. Artificial Intelligence in Genomics Market, by Application

  • 8.1. Introduction
  • 8.2. Agriculture & Animal Research
  • 8.3. Diagnostics
  • 8.4. Drug Discovery & Development
  • 8.5. Precision Medicine

9. Artificial Intelligence in Genomics Market, by End-User

  • 9.1. Introduction
  • 9.2. Government Organizations
  • 9.3. Healthcare Providers
  • 9.4. Pharmaceutical & Biotech Companies
  • 9.5. Research Centers & Academic Institutes

10. Americas Artificial Intelligence in Genomics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Artificial Intelligence in Genomics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Artificial Intelligence in Genomics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. BenevolentAI Ltd.
  • 2. Data4Cure Inc.
  • 3. Deep Genomics Inc.
  • 4. DNAnexus Inc.
  • 5. Engine Biosciences Pte. Ltd.
  • 6. Exscientia
  • 7. Fabric Genomics Inc.
  • 8. FDNA Inc.
  • 9. Freenome Holdings, Inc.
  • 10. Genomics AI
  • 11. Genoox Ltd.
  • 12. Illumina, Inc.
  • 13. insitro
  • 14. International Business Machines Corporation
  • 15. Invitae Corporation
  • 16. LGC Biosearch Technologies
  • 17. Lifebit Biotech Ltd
  • 18. Microsoft Corporation
  • 19. MolecularMatch, Inc.
  • 20. NVIDIA Corporation
  • 21. Ocean Genomics
  • 22. Owkin, Inc
  • 23. PrecisionLife Ltd.
  • 24. Sophia Genetics SA
  • 25. Verge Genomics

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET DYNAMICS
  • TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CLINICAL WORKFLOWS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY RESEARCH CENTERS & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, FPNV POSITIONING MATRIX, 2023